Search

Your search keyword '"Boulet, L.P."' showing total 92 results

Search Constraints

Start Over You searched for: Author "Boulet, L.P." Remove constraint Author: "Boulet, L.P."
92 results on '"Boulet, L.P."'

Search Results

1. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

2. Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN)

3. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

4. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

5. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

6. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases

7. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

8. Influence of inhaled corticosteroids and dietary intake on bone density and metabolism in patients with moderate to severe asthma

9. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases

10. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

11. Mask 2017: Aria Digitally-Enabled, Integrated, Person-Centred Care For Rhinitis And Asthma Multimorbidity Using Real-World-Evidence

12. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

13. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

14. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)

15. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

16. WITHDRAWN: Scaling up strategies of the Chronic Respiratory Disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3 – Area 5)

17. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation

18. WITHDRAWN: Scaling up strategies of the Chronic Respiratory Disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3 – Area 5)

19. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

20. Integrated care pathways for airway diseases (AIRWAYS-ICPs)

21. Severe chronic allergic (and related) diseases: A uniform approach - A MeDALL - GA2 LEN - ARIA position paper

22. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

23. Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper

24. Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper

25. Integrated care pathways for airway diseases (AIRWAYS-ICPs)

26. Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper.

27. Severe chronic allergic (and related) diseases: A uniform approach - A MeDALL - GA 2 LEN - ARIA position paper

28. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

29. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

30. A new perspective on concepts of asthma severity and control

31. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).

32. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

44. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: A Canadian multicenter study

45. Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model

Catalog

Books, media, physical & digital resources